Advertisement

Menopausal Hormone Therapy After Breast Cancer in BRCA Carriers
Posted: 09/08/2025 | By: Custom Content Team

Use of menopausal hormone therapy (MHT) is contraindicated in women with a history of breast cancer. Take this quiz to test your understanding of a recent prospective analysis, presented at the 2025 ASCO Annual Meeting, on MHT use in patients with BRCA mutations after a diagnosis of breast cancer.

Question 1 of 5

What was the main purpose of this study?

Choose 1

A
To compare adverse events associated with systemic vs local menopausal hormone therapy (MHT) in patients with breast cancer
B
To evaluate the association of MHT use after a diagnosis of breast cancer and risk of death in women who are BRCA carriers
C
To determine the most effective formulation of MHT in BRCA carriers
D
To study oophorectomy outcomes in BRCA carriers after MHT use

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage